ReviewInternational journal of molecular sciences2014

The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, Hepatic Cytochrome P450 Reductase Null (HRN™) mice and pure enzymes.

Marie Stiborová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.